Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: A comparison between immunocompetent and immunocompromised patients

Journal of Hepatology

Volumn 29, Issue 1, 1998, Pages 12-19

  Pol, Stanislas ^a,b   Fontaine, Hélène ^a   Carnot, Françoise ^a   Zylberberg, Hervé ^a   Berthelot, Pierre ^a   Bréchot, Christian ^a,b   Nalpas, Bertrand ^a,b  

^a Hopital Laennec   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cirrhosis; Hepatitis C virus; Immune deficiency

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ABUSE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; VIRUS LOAD;

EID: 0032124862     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80173-6     Document Type: Article

References (40)

1. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol. 16:1992;273-281.
2. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long-term prognosis of hepatitis C virus infection in Japan. Gut. 34:1993;13-16. (suppl).
3. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 122:1995;161-168.
4. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factor of sustained response to interferon alpha therapy in chronic hepatitis C. Hepatology. 22:1995;1050-1056.
5. Feray C, Gigou M, Samuel D, Paradis V, Brechot C, Bismuth H, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology. 20:1994;1137-1143.
6. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatitis C virus genotype in patients with and without liver function abnormalities. Hepatology. 21:1995;285-290.
7. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C; a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology. 23:1996;695-699.
8. Mita E, Hayashi N, Kanazawa Y, Hagiwara H, Ueda K, Kasahara A, et al. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol. 21:1994;468-473.
9. Oshita M, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M, et al. Increased serum hepatitis virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology. 20:1994;1115-1120.
10. Fong TL, Kanel GC, Conrad A, Valinluck B, Charbonneau F, Adkins RH. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology. 19:1994;554-557.
11. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, et al. Long-term mortality after transfusion associated non-A, non-B hepatitis. The national heart, lung, and blood institute study group. N Engl J Med. 327:1992;1906-1911.
12. Darby SC, Ewart DW, Giangrande PLF, Spooner RJD, Rizza CR, Dusheiko GM, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet. 350:1997;1425-1431.
13. Tong MJ, El-Farra NS, Reikes AR, Co LR. Clinical outcomes after transfusion associated hepatitis C. N Engl J Med. 332:1995;1463-1466.
14. Alter M, Margolis H, Krawczynski K, Judson F, Mares A, Alexander J, et al. The natural history of community acquired hepatitis C in United States. N Engl J Med. 327:1992;1899-1905.
15. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology. 14:1991;969-974.
16. Mattsson L, Weiland O, Glaumann H. Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcome. Liver. 8:1988;184-188.
17. Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The hepatitis C study group. Ann Intern Med. 123:1995;330-337.
18. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology. 24:1996;778-789.
19. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet. 349:1997;825-832.
20. Roudot-Thoraval F, Bastie A, Pawlotsky J-M, Dhumeaux D. . and the study group for the prevalence and the epidemiology of hepatitis C virus Hepatology. 26:1997;485-490.
21. Lucidarme D, Foutrein P, Creusy C, Forzy G, Foutrein-Comes M-C, Muyssen A, et al. Prevalence of serological markers of hepatitis C, B and D and histological aspects in intravenous drug users. Gastroenterol Clin Biol. 18:1994;964-968.
22. Thiers V, Jaffredo F, Tuveri R, Chodan N, Bréchot C. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Virol Methods. 65:1997;9-17.
23. Knodell R, Ishak K, Black W, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
24. Martin P, Bisceglie AD, Kassiandes C, Lisker-Melmav M, Hoofnagle J. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 97:1989;1559-1561.
25. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 171:1995;1607-1610.
26. Pol S, Thiers V, Nousbaum J-B, Legendre C, Berthelot P, Kreis H, et al. The changing prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology. 108:1995;581-583.
27. Goodson JD, Taylor PA, Campion EW, Richter JM, Wands J. The clinical course of acute hepatitis in the elderly patient. Arch Intern Med. 142:1982;1485-1488.
28. Laverdant C, Algayres J-P., Daly J-P, Molinié A, Flechaire A, Valmary J, et al. Clinical, etiologic and evolutive features of viral hepatitis in the elderly (78 cases). Gastroenterol Clin Biol. 13:1989;499-504.
29. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OFW. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology. 9:1989;297-301.
30. Nagel JE, Chrest JJ, Adler HH. Enumeration of T lymphocytes by monoclonal antibodies in young and aged humans. J Immunol. 151:1991;599-603.
31. Mendenhall CL, Rouster SD, Roselle GA, Grossman CJ, Ghosn S, Gartside P. Impact of chronic alcoholism on the aging rat: changes in nutrition, liver composition, and mortality. Alcohol Clin Exp Res. 17:1993;847-853.
32. Chang M-P, Norman DC, Makinodan T. Immunotoxicity of alcohol in young and old mice. I. In vitro suppressive effects of ethanol on the activities of T and B immune cells of aging mice. Alcohol Clin Exp Res. 14:1990;210-215.
33. Makinodan T, Kay MMB. Age influence on the immune system. Adv Immunol. 29:1980;287-291.
34. Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C. Fluctuations of hepatitis C quasispecies in persistent infection and interferon treatment revealed by single strand conformation polymorphism analysis. J Gen Virol. 75:1994;1361-1369.
35. LeGuen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Bréchot C. HCV genome complexity correlates with response to interferon therapy. A study in French patients with chronic hepatitis C. Hepatology. 1997;. (in press).
36. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, et al. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology. 19:1994;273-279.
37. Befrits R, Hedman M, Blomquist L, Allander T, Grillner L, Kinnman N, et al. Chronic hepatitis C in alcoholic patient: prevalence genotypes and correlation to liver disease. Scand J Gastroenterol. 30:1995;1113-1118.
38. Lieber CS. Medical disorders of alcoholism. N Engl J Med. 333:1996;1058-1065.
39. Zylberberg H, Carnot F, Mamzer MF, Blancho G, Legendre C, Pol S. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation. 63:1997;158-160.
40. Lau JYN, Bain VG, Davies SE, O' Grady JG, Alberti A, Alexander GJM, et al. High level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology. 102:1992;956-962.